Metabolism - Clinical and Experimental
Volume 52, Issue 3 , Pages 279-281 , March 2003

Interactions of apolipoprotein E genotype and dietary fat intake of healthy older persons during mid-adult life

Received 24 October 2001 ,Accepted 16 October 2002.

References 

  1. Finch CE, Tanzi RE. Genetics of aging. Science. 1997;278:407–411
  2. Simopoulos AP. Genetic variation and nutrition. Nutr Rev. 1999;57:S10–S19
  3. Corder EH, Saunders AM, Strittmatter WJ, et al.  Gene dose of apolipoprotein E type allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921–923
  4. Farrer LA, Cupples LA, Haines JL, et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. JAMA. 1997;278:1349–1356
  5. Hofman A, Ott A, Breteler MB, et al.  Athersclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997;349:151–154
  6. Notkola IL, Sulkava R, Pekkanen J, et al.  Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology. 1998;17:14–20
  7. Lopez-Miranda J, Ordovas JM, Mata P, et al.  Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res. 1994;35:1965–1975
  8. Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr. 2000;71(suppl):621S–629S
  9. Friedland RP, Fritsch T, Smyth KA, et al.  Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members. Proc Natl Acad Sci USA. 2001;98:3440–3445
  10. Morris JC, Heyman A, Mohs AC, et al.  The Consortium to Establish a Registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39:1159–1165
  11. Welsh KA, Butters N, Mohs RC, et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology. 1994;44:609–614
  12. Block G, Coyle LM, Hartman AM, et al.  Revision of dietary analysis software for the Health Habits and History Questionnaire. Am J Epidemiol. 1994;139:1190–1196
  13. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;63(suppl):1220S–1228S
  14. Cobb MM, Teitlebaum H, Risch N, et al.  Influence of dietary fat, apolipopotein E phenotype, and sex on plasma lipoprotein levels. Circulation. 1992;86:849–857
  15. Berglund L. The APOE gene and diets—Food (and drink) for thought. Am J Clin Nutr. 2001;73:669–670
  16. Perusse L, Bouchard C. Gene-diet interactions in obesity. Am J Clin Nutr. 2000;72(suppl):1285S–1290S
  17. Ewbank DC. Mortality differences by APOE genotype estimated from demographic synthesis. Gen Epidemiol. 2002;22:146–155
  18. Mattson MP. Neuroprotective signaling and the aging brain: Take away my food and let me run. Brain Res. 2000;886:47–53
  19. Byers T, Marshall J, Anthony E, et al.  The reliability of dietary history from the distant past. Am J Epidemiol. 1987;125:999–1011
  20. Dwyer JT, Gardner J, Halvorsen K, et al.  Memory of food intake in the distant past. Am J Epidemiol. 1989;130:1033–1046
  21. Dwyer JT, Coleman KA. Insights into dietary recall from a longitudinal study: Accuracy over four decades. Am J Clin Nutr. 1997;65(suppl):1153S–1158S
  22. Willett W. Recall of remote diet. In: ed 2.  Willett W editors. Nutritional Epidemiology. New York, NY: Oxford; 1998;p. 148–156
  23. Stephen AM, Wald NJ. Trends in individual consumption of dietary fat in the United States, 1920-1984. Am J Clin Nutr. 1990;52:457–469
  24. O'Hara R, Yesavage JA, Kraemer HC, et al.  The APOE ϵ4 allele is associated with decline on delayed recall performance in community-dwelling older adults. J Am Geriatr Soc. 1998;46:1493–1498
  25. Caselli RJ, Graff-Radford NR, Reiman EM, et al.  Preclinical memory decline in cognitively normal apolipoprotein E-e4 homozygotes. Neurology. 1999;53:201–207
  26. Feskens EJM, Havekes LM, Kalmijn S, et al.  Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ. 1994;309:1202–1206
  27. Dik MG, Jonker C, Bouter LM, et al.  APOE-e4 is associated with memory decline in cognitively impaired elderly. Neurology. 2000;54:1492–1497
  28. Riley KP, Snowden DA, Saunders AM, et al.  Cognitive function and apolipoprotein E in very old adults: Findings from The Nun Study. J Gerontol B Psychol Sci Soc Sci. 2000;55B:S69–S75
  29. Small BJ, Graves AB, McEvoy CL, et al.  Is APOE-e4 a risk factor for cognitive impairment in normal aging?. Neurology. 2000;54:2082–2088

☆ Supported in part by Grant No. P50 AG 08012 from the National Institute on Aging, the Joseph and Florence Mandel Foundation, the Nickman family, The Institute for the Study of Aging, NY, Philip Morris, USA, and The Fullerton Family Foundation.

☆☆ Address reprint requests to Grace J. Petot, MS, University Memory and Aging Center, 12200 Fairhill Rd, Cleveland, OH 44120-1013.

PII: S0026-0495(02)05202-2

doi: 10.1053/meta.2003.50066

Metabolism - Clinical and Experimental
Volume 52, Issue 3 , Pages 279-281 , March 2003

Article Tools